These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29953191)

  • 1. Aspirin Resistance in Different Doses by Bleeding Time and Urinary 11-dehydro-thromboxane B2.
    Maleki A; Cheraghi M; Kerman SRJ; Montazeri M; Rashidi N; Ghanavati R; Foroughi S; Alyari F; Ahmadvand H
    Indian J Physiol Pharmacol; 2016; 60(1):30-7. PubMed ID: 29953191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease].
    Liu H; Chen Z; Gao R
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):595-8. PubMed ID: 8697924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin dosage and thromboxane synthesis in patients with vascular disease.
    Hart RG; Leonard AD; Talbert RL; Pearce LA; Cornell E; Bovill E; Feinberg WM
    Pharmacotherapy; 2003 May; 23(5):579-84. PubMed ID: 12741431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor.
    Ikonomidis I; Andreotti F; Nihoyannopoulos P
    Heart; 2004 Apr; 90(4):389-93. PubMed ID: 15020512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
    Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
    Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
    Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
    Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
    Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
    Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
    Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
    Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
    Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
    Gao F; Wang ZX; Men JL; Ren J; Wei MX
    Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.